Barclays’s Avanos Medical AVNS Stock Holding History

Barclays’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-35,000	Closed	-$2M	–	7106
2018 Q2	$2M	Buy	+35,000	New	+$1.85M	﹤0.01%	2585
2017 Q1	–	Sell	-96	Closed	-$4K	–	6741
2016 Q4	$4K	Hold	96	–	–	﹤0.01%	6168
2016 Q3	$3K	Hold	96	–	–	﹤0.01%	6119
2016 Q2	$3K	Hold	96	–	–	﹤0.01%	5845
2016 Q1	$3K	Sell	96 -732	-88%	-$19.5K	﹤0.01%	5778
2015 Q4	$27K	Hold	828	–	–	﹤0.01%	5090
2015 Q3	$23K	Hold	828	–	–	﹤0.01%	5388
2015 Q2	$33K	Sell	828 -240	-22%	-$10.8K	﹤0.01%	5394
2015 Q1	$52K	Sell	1,068 -3,528	-77%	-$163K	﹤0.01%	5249
2014 Q4	$207K	Buy	+4,596	New	+$181K	﹤0.01%	4606

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Barclays's AVNS Position: Q2 2026 in Review

Barclays increased its Avanos Medical (AVNS) stake by 961% in Q2 2026, buying an estimated $3.1M and bringing the position to 146,207 shares worth $3.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Barclays first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $5.7M in Q3 2018. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Barclays held 146,207 shares of Avanos Medical worth $3.64M as of Q2 2026.
Barclays bought 132,421 Avanos Medical shares in Q2 2026, an estimated $3.1M.
Avanos Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2014 holding.
Barclays first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
Barclays's Avanos Medical position peaked at $5.7M in Q3 2018.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.